Related Experiment Video
Updated: May 13, 2026
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial
Renata S M Gomes1, Ricardo Pires das Neves, Lowri Cochlin
1CNC, Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
ACS Nano
|March 5, 2013
Summary
Biodegradable nanoparticles loaded with perfluoro-1,5-crown ether (PFCE) enable in vivo cell tracking via MRI and efficient miRNA delivery. This approach significantly enhances endothelial cell survival and blood perfusion in ischemic limbs.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression.
- Efficient and targeted delivery of miRNAs remains a challenge in therapeutic applications.
- In vivo cell tracking is essential for monitoring therapeutic efficacy.
Purpose of the Study:
- To develop biodegradable nanoparticles (NPs) for combined miRNA delivery and in vivo cell tracking.
- To investigate the cellular localization and protein interactions of the novel NPs.
- To evaluate the therapeutic potential of miRNA-loaded NPs in promoting tissue repair.
Main Methods:
- Synthesis of biodegradable nanoparticles (NP170-PFCE) encapsulating perfluoro-1,5-crown ether (PFCE).
- Complexation of miRNAs with NP170-PFCE and assessment of cellular uptake and localization using microscopy.
- Analysis of protein interactions (Ago2, GW182) within the endolysosomal compartment.
- In vivo evaluation of endothelial cell survival and blood perfusion in ischemic limbs following NP treatment.
Main Results:
- NP170-PFCE nanoparticles successfully tracked cells in vivo using magnetic resonance imaging (MRI).
- NP170-PFCE complexes preferentially accumulated in the endolysosomal compartment, enhancing interaction with key miRNA-processing proteins.
- Release of miRNA132 (miR132) from NPs resulted in a 3-fold increase in transplanted endothelial cell survival.
- A 3.5-fold increase in blood perfusion was observed in ischemic limbs treated with miR132-loaded NPs.
Conclusions:
- Biodegradable nanoparticles offer a promising platform for simultaneous in vivo cell tracking and targeted miRNA delivery.
- The endolysosomal localization of NP170-PFCE enhances miRNA therapeutic efficacy compared to commercial reagents.
- This nanomedicine approach demonstrates significant potential for improving outcomes in regenerative medicine and treating ischemic conditions.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...